Today

Agents

Chat

Arena

Discover

More

App

Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly - LLY News | Rallies

Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly

LLY•2026-08-04

Collaboration and supply agreement with Lilly

Amplia Therapeutics signs collaboration and supply agreement with Lilly
Lilly to evaluate narmafotinib and olomorasib combination
Study to begin in late 2026 in Australia and the USA
Signs collaboration agreement with Lilly for NSCLC study

Related News

Tetra Q2 FY26 revenue rises 7% to $185.7 million; net income from continuing operations falls 10% to $10.2 million

TTI•2026-08-03

Nasdaq Trade Halt <AEMD.O> Halt News Pending at 07:50 PM

AEMD•2026-08-03

Matson Q2 revenue rises on China demand, raises outlook

•

2026-08-03

Hanover Bancorp President Kevin M. O’Connor acquires $268,800 of common shares

HNVR•2026-08-03

Cushman & Wakefield: Japanese capital drives APAC Living investment, Australia emerges as key growth market

CWK•2026-08-04